INTERNATIONAL PATENT: OPELLA HEALTHCARE GROUP SAS FILES APPLICATION FOR "FIXED DOSAGE COMBINATION OF METAMIZOLE, CAFFEINE AND CHLORPHENIRAMINE MALEATE"

GENEVA, March 17 -- OPELLA HEALTHCARE GROUP SAS (157 Avenue Charles de Gaulle92200 NEUILLY SUR SEINE) filed a patent application (PCT/EP2023/074678) for "FIXED DOSAGE COMBINATION OF METAMIZOLE, CAFFEINE, AND CHLORPHENIRAMINE MALEATE" on Sep 07, 2023. With publication no. WO/2025/051372, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOS REIS SANTOS, Luiz Paulo (Rua Conde Domingos Papais, 413,Jardim Natal, Suzano08613-901 Sao Paulo), DRUMOND, Thais Leme (Rua Conde Domingos Papais, 413,Jardim Natal, Suzano08613-901 Sao Pau...